Clinical trials
Recruiting Influenza, Human trials in China
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
8 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2022 | 1 |
| 2024 | 3 |
| 2025 | 4 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 8 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Jiangxi Qingfeng Pharmaceutical Co. Ltd. | 2 |
| Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd. | 1 |
| AstraZeneca | 1 |
| Capital Medical University | 1 |
| Ruijin Hospital | 1 |
| Shanghai Institute Of Biological Products | 1 |
| Zhongnan Hospital | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Influenza, Human | 8 |
| COVID-19 | 2 |
| Coronavirus Infections | 1 |
| Infections | 1 |
| Lung Diseases | 1 |
| Respiratory Distress Syndrome | 1 |
| Respiratory Tract Infections | 1 |
| Severe Acute Respiratory Syndrome | 1 |
| Virus Diseases | 1 |
Trials
Showing 1 to 8 of 8. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.